We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Dynamic Light Scattering Allows Measurement of Allosteric Transitions of Single Molecules

By LabMedica International staff writers
Posted on 30 Jul 2012
A biotech research laboratory used a state-of-the-art dynamic light scattering (DLS) system to study structural rearrangements in single Escherichia coli proteins.

Investigators at the National Autonomous University of Mexico (Mexico City, Mexico) relied on a Malvern Instruments (Malvern, United Kingdom) Zetasizer µV dynamic light scattering (DLS) system to analyze allosteric transitions (molecular rearrangements) in the hexameric glucosamine-6-phosphate deaminase protein from E. More...
coli, which changes its shape to a more compact form upon allosteric-activator binding. This change can be measured with an instrument such as the Zetasizer.

The Zetasizer series of instruments measures particle and molecule size from below a nanometer to several microns using dynamic light scattering, zeta potential, and electrophoretic mobility using electrophoretic light scattering, and molecular weight using static light scattering. In addition, the system can be connected to a GPC (gel permeation chromatograph)/SEC (size exclusion chromatograph) system to use as a chromatography detector.

“We use the Zetasizer µV to characterize the size of proteins and how they interact to produce multimeric forms or even supramolecular arrangements of the protein such as viral capsids,” said Dr. Ismael Bustos-Jaimes, professor of biochemistry at the National Autonomous University of Mexico. “The Zetasizer µV allows us to work with sizes in the range of one nm to 500 nm and follow each assembly and stability parameter, such as pH, temperature, and ionic strength, guiding us to the optimal production conditions for these virus-like particles.”

“The Zetasizer µV software is user-friendly and in addition to measuring particle size it delivers information about the quality of sample preparation. This is very important when you work with molecules, which are prone to uncontrolled aggregation,” said Dr. Bustos-Jaimes.

Related Links:
National Autonomous University of Mexico
Malvern Instruments



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Online QC Software
Acusera 24•7
Clinical Informatics Platform
CLARION™
Electrolyte Analyzer
CBS-4000 (CBS-400)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Characterization of EV separated by distinct methods (Photo courtesy of Yuanyuan Liu, Yanbin Guo et al. Engineering, doi.org/10.1016/j.eng.2025.12.009)

Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read more

Molecular Diagnostics

view channel
Image: Associate Professor Arutha Kulasinghe and non-small cell lung cancer cell (Photo courtesy of The University of Queensland)

Blood-Based Proteomic Test May Predict Treatment Response in Non-Small Cell Lung Cancer

Lung cancer remains the leading cause of cancer death, with non-small cell lung cancer (NSCLC) accounting for most cases. Treatment decisions are often made without a clear indication of how a patient... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.